Full-Dose Antithrombotic Aids Selected COVID-19 ICU Patients
Compared with reduced-dose prophylaxis, full-dose anticoagulation cut thrombotic events but also boosted bleeding in patients with COVID-19 who needed ICU admission.
Source: medscape.com
Eduardo Ramacciotti News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Eduardo Ramacciotti. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Eduardo Ramacciotti Today - Breaking & Trending Today
COVID-PACT: Full-Dose Anticoagulation Improves Outcomes in Critical COVID-19
For less-sick patients, results from the ACT trials showed no benefits with colchicine, aspirin, or rivaroxaban plus aspirin.
Source: tctmd.com
Full-Dose Anticoagulation Cuts VTE in Severe COVID-19
But is it worthwhile without a mortality benefit? Trials present complex picture
Source: medpagetoday.com
Managing Cardiovascular Complications of COVID Vaccination
At a recent conference, cardiologists discussed the management of myopericarditis and myocarditis after SARS-CoV-2 infection, as well as the cardiac rehabilitation process.
Source: medscape.com
Rivaroxaban Improves Clinical Outcomes After COVID-19 Hospitalization
Risk for thrombotic events reduced after 35 days of rivaroxaban compared with no extended thromboprophylaxis
Source: renalandurologynews.com